Genesis Genomics is a cancer biomarker discovery company that enables early detection and characterization of many types of cancer at molecular level. The company has developed the Biomarker Discovery Platform which is a multi application molecular screening technology that provides clinicians for early screening and also as a better prognostic indicator. It also develops a technology that extends life and decreases treatment costs, assays and services for prostrate and skin cancers. Its technologies also help in improving the quality of life for potential cancer patients. It is headquartered in Ontario, Canada.